AstraZeneca has become the latest major drugmaker to scale back investment in the United Kingdom, pausing a planned £200 million ($271 million) expansion of its Cambridge research site. The move, which would have created up to 1,000 jobs, highlights growing tensions between the pharmaceutical industry and the UK government over…
With US equities hovering near record levels and economics indicators flashing warning signs – Morgan Stanley is urging investors to seek shelter in companies with robust free cash flows.According to the investment firm, “cash-rich” businesses are better equipped to navigate volatility, thanks to their ability to self-finance operations and growth.Amid…
Markets ended the week with a mix of corporate developments, economic data, and breaking news shaping investor sentiment. Tesla shares’ sharp rebound, weakening US consumer confidence, the capture of a high-profile murder suspect, Gemini’s upcoming stock debut, and fresh moves in US equities all made headlines Friday.Tesla stock surges on…
The world’s largest asset manager is set to use President Donald Trump’s state visit to the United Kingdom next week as the backdrop for a significant announcement, reported Sky News. BlackRock will unveil a £500m plan to invest in UK data centres, a move that highlights the rapid growth of…
UK’s Investment Security Unit (ISU) has cleared IonQ Inc’s (NYSE: IONQ) more than $1.0 billion acquisition of Oxford Ionics. The quantum computing stock soared nearly 20% on the news today.The regulatory green light removes the final hurdle for the aforementioned transaction, which now looks set to close imminently.Today’s rally pushed…
Gemini stock is all set to debut on the Nasdaq, marking a significant milestone in the cryptocurrency sector by being oversubscribed 20 times and raising $425 million at $28 per share.This strong investor appetite highlights growing confidence in Gemini’s potential as a major player in the crypto exchange space. The…
Tesla stock rose over 7% on Friday, lifted by renewed investor optimism despite concerns over weak sales, stretched valuations, and Chief Executive Elon Musk’s strategic shift toward artificial intelligence and robotics. The rally marked a sharp reversal for the Tesla stock that has struggled this year, weighed down by the…
Tempus AI stock price surged to a record high on Wednesday after the healthcare-focused artificial intelligence company announced a major breakthrough from the Food and Drug Administration (FDA). It jumped to a high of $91, which coincided with the highest point in February this year.Why Tempus AI stock is soaring Tempus…
Friday’s news wrap covers major developments shaping global politics, technology, and security. A suspect has been arrested in the murder of conservative activist Charlie Kirk, sparking outrage.Meanwhile, the FTC is probing Amazon and Google’s ad practices, Nvidia and OpenAI are backing UK AI hubs, and the US urges G7 allies…
AstraZeneca has become the latest major drugmaker to scale back investment in the United Kingdom, pausing a planned £200 million ($271 million) expansion of its Cambridge research site. The move, which would have created up to 1,000 jobs, highlights growing tensions between the pharmaceutical industry and the UK government over…